ASTRAZENECA FDA Approval NDA 018257

NDA 018257

ASTRAZENECA

FDA Drug Application

Application #018257

Application Sponsors

NDA 018257ASTRAZENECA

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET;ORAL400MG0TONOCARDTOCAINIDE HYDROCHLORIDE
002TABLET;ORAL600MG0TONOCARDTOCAINIDE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1984-11-09PRIORITY
LABELING; LabelingSUPPL2AP1985-02-25PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1985-02-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1985-01-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1985-01-30PRIORITY
LABELING; LabelingSUPPL6AP1985-05-13PRIORITY
LABELING; LabelingSUPPL7AP1985-05-13PRIORITY
LABELING; LabelingSUPPL8AP1986-04-17PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1985-09-13PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1986-02-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1988-08-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1987-01-21PRIORITY
LABELING; LabelingSUPPL14AP1987-08-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1987-06-01PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1987-07-07PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1988-04-07PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1989-12-07PRIORITY
LABELING; LabelingSUPPL19AP1989-07-10PRIORITY
LABELING; LabelingSUPPL20AP1992-09-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1992-10-08PRIORITY
LABELING; LabelingSUPPL23AP1995-11-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1997-11-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1997-10-27PRIORITY
LABELING; LabelingSUPPL26AP1999-07-07PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL27AP2000-06-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2001-01-18PRIORITY
LABELING; LabelingSUPPL29AP2001-10-24PRIORITY

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0

CDER Filings

ASTRAZENECA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18257
            [companyName] => ASTRAZENECA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TONOCARD","activeIngredients":"TOCAINIDE HYDROCHLORIDE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"TONOCARD","activeIngredients":"TOCAINIDE HYDROCHLORIDE","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TONOCARD","submission":"TOCAINIDE HYDROCHLORIDE","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"TONOCARD","submission":"TOCAINIDE HYDROCHLORIDE","actionType":"600MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.